Phibro Animal Health Corporation
PAHC
$22.93
-$0.71-3.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.11B | 1.05B | 1.02B | 999.56M | 982.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.11B | 1.05B | 1.02B | 999.56M | 982.01M |
| Cost of Revenue | 752.12M | 717.38M | 704.07M | 696.44M | 683.16M |
| Gross Profit | 353.96M | 329.38M | 313.61M | 303.13M | 298.86M |
| SG&A Expenses | 216.42M | 211.81M | 217.89M | 215.99M | 213.49M |
| Depreciation & Amortization | 2.99M | 2.99M | 2.99M | 3.05M | 3.05M |
| Other Operating Expenses | 4.20M | 4.20M | 4.20M | 0.00 | 325.00K |
| Total Operating Expenses | 1.00B | 965.57M | 958.34M | 939.87M | 924.41M |
| Operating Income | 101.16M | 81.19M | 59.34M | 59.70M | 57.60M |
| Income Before Tax | 33.79M | 32.52M | 10.92M | 25.95M | 28.13M |
| Income Tax Expenses | 14.47M | 15.11M | 8.50M | 12.79M | 13.33M |
| Earnings from Continuing Operations | 19.32 | 17.41 | 2.42 | 13.16 | 14.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.32M | 17.41M | 2.42M | 13.16M | 14.80M |
| EBIT | 101.16M | 81.19M | 59.34M | 59.70M | 57.60M |
| EBITDA | 138.70M | 116.07M | 94.08M | 93.79M | 90.99M |
| EPS Basic | 0.48 | 0.43 | 0.06 | 0.33 | 0.37 |
| Normalized Basic EPS | 0.82 | 0.65 | 0.26 | 0.42 | 0.44 |
| EPS Diluted | 0.47 | 0.43 | 0.06 | 0.32 | 0.36 |
| Normalized Diluted EPS | 0.82 | 0.65 | 0.26 | 0.42 | 0.44 |
| Average Basic Shares Outstanding | 162.01M | 162.01M | 162.01M | 162.01M | 162.01M |
| Average Diluted Shares Outstanding | 162.42M | 162.21M | 162.13M | 162.03M | 162.01M |
| Dividend Per Share | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
| Payout Ratio | 100.64% | 111.70% | 804.72% | 147.71% | 131.38% |
